Director – AI Commercial Product Strategy
IBEX
Director – AI Commercial Product Strategy
IBEX
Biotech company: antibodies and gene therapy
Reporting to and supporting the SVP of Wave iX, The Director of AI Commercial Product Strategy is a commercially oriented leader responsible for turning AI Agent capabilities into compelling, differentiated, and sellable solutions that create measurable value for clients and revenue for ibex.
This role requires a strong communicator capable of leading discovery conversations, engaging confidently with clients and executive stakeholders, synthesizing ambiguous information, and turning complex capabilities into clear business recommendations.
The role considers market intelligence, partner capabilities, client feedback, competitive insights, solution messaging, and ROI models into a coherent commercialization message.
This Director works across Sales and Client Services, AI Technology Partners, Marketing, and the Wave iX team to ensure solution offerings evolve to meet client needs and opportunities.
This role works alongside internal Sales and CS, and is a counterpart to the AI technology partners’ account teams, including Account Executives and Solutions Engineering. It translates partner product roadmaps and proof-points into ibex-branded commercial assets, identifies co-selling opportunities, and helps ibex teams win and expand business.
This role does not own engineering, implementation, or delivery. Technical fluency is important, but coding or engineering ownership is not required. This Director will ensure that the commercial organization knows what to sell, why clients buy it, how to differentiate it, and how to build a credible business case.
1. Commercial Strategy and Go-to-Market
Support the SVP of Wave iX with the commercial strategy and go-to-market plan for the AI Agent product at ibex.
Responsibilities include:
2. Client Discovery, Critical Thinking, and Use Case Development
Lead the development of repeatable AI Agent use cases grounded in real customer problems, buying priorities, operational constraints, and measurable outcomes.
Examples include:
The role will likely participate in or lead:
Each use case includes:
Each use case should reference existing proof points, such as cost-reduction and resolution-rate benchmarks from live customer deployments, so representatives are not building ROI narratives from scratch for every deal.
3. Value Proposition, Messaging, and Executive Communication
Serve as a compelling storyteller for the AI Agent offer.
Develop and maintain:
Present and adapt the story for different audiences, including prospects, clients, executive leaders, Sales, Marketing, Operations, Solutions, and technology partners. Make the business case clear without oversimplifying the underlying product realities.
Ensure consistent messaging across Sales, Marketing, Client Success, and Executive Leadership.
4. Sales Enablement and Strategic Deal Support
Create commercial assets and provide hands-on support that accelerate revenue and improve seller confidence.
Examples include:
Support priority opportunities directly through discovery preparation, value proposition development, business-case creation, objection handling, executive meeting preparation, RFP responses, and deal reviews.
Measure adoption and continuously improve these assets using seller feedback, client feedback, win/loss insights, and pipeline outcomes.
Own and continuously refine the demo sequencing playbook based on live deal feedback, including lessons such as leading with lower-risk, non-revenue intents before higher-stakes automation when appropriate.
Success Measures (KPIs)
Core Competencies
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Explore more opportunities at IBEX